Recently, the Market Supervision Bureau of Hebei Province and the Provincial Drug Administration jointly introduced several measures to promote the high-quality development of the biopharmaceutical industry. Vigorously support R&D innovation and stimulate the vitality of business entities. Strengthen assistance and guidance, guide enterprises to carry out new drug research and development guided by clinical needs, steadily promote the evaluation of the quality and efficacy consistency of generic drugs, help enterprises and research and development units communicate and coordinate with the National Drug Administration, and develop and produce more "Chinese drugs" that are suitable for the inheritance of life genes and physical fitness characteristics of Chinese people. Gradually promote the self construction, co construction, joint construction, and sharing of traditional Chinese medicine planting and breeding bases by traditional Chinese medicine production enterprises. Open a green channel for review and approval. For projects listed in national and provincial major science and technology projects or national and provincial key research and development plans, as well as projects identified as diagnosis or treatment of Rare disease, malignant tumors, endemic and frequently occurring diseases of the elderly, clinical needs, and there is no similar product on the market in China, shorten the time limit, queue up separately, and give priority to inspection, testing, registration, verification, review and approval. Select the best to include national demonstration enterprises with intellectual property advantages in biomedicine and "little giant" enterprises with expertise, specialty and novelty into the first batch of pilot enterprises for the implementation of international intellectual property standards in Innovation management. Intensify efforts to crack down on intellectual property violations in the biopharmaceutical field and strengthen intellectual property protection. Promote the construction of the National Quality Inspection Center for Traditional Chinese Medicine Products, and establish an efficient and authoritative research system for traditional Chinese medicine inspection, testing, and quality control that integrates functions such as quality inspection, testing technology research and development, standard formulation and revision, and technical services. (Outlook New Era Network)